• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有独特基因组亚类的头颈部癌症的特征。

Hallmarks of a genomically distinct subclass of head and neck cancer.

机构信息

Amsterdam UMC, location Vrije Universiteit Amsterdam, Otolaryngology / Head and Neck Surgery, Amsterdam, The Netherlands.

Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.

出版信息

Nat Commun. 2024 Oct 20;15(1):9060. doi: 10.1038/s41467-024-53390-3.

DOI:10.1038/s41467-024-53390-3
PMID:39428388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11491468/
Abstract

Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key characteristics of cancer development. Nonetheless, some tumors show hardly any CNAs, a remarkable phenomenon in oncogenesis. Head and neck squamous cell carcinomas (HNSCCs) arise by either exposure to carcinogens, or infection with the human papillomavirus (HPV). HPV-negative HNSCCs are generally characterized by many CNAs and frequent mutations in CDKN2A, TP53, FAT1, and NOTCH1. Here, we present the hallmarks of the distinct subgroup of HPV-negative HNSCC with no or few CNAs (CNA-quiet) by genetic profiling of 802 oral cavity squamous cell carcinomas (OCSCCs). In total, 73 OCSCC (9.1%) are classified as CNA-quiet and 729 as CNA-other. The CNA-quiet group is characterized by wild-type TP53, frequent CASP8 and HRAS mutations, and a less immunosuppressed tumor immune microenvironment with lower density of regulatory T cells. Patients with CNA-quiet OCSCC are older, more often women, less frequently current smokers, and have a better 5-year overall survival compared to CNA-other OCSCC. This study demonstrates that CNA-quiet OCSCC should be considered as a distinct, clinically relevant subclass. Given the clinical characteristics, the patient group with these tumors will rapidly increase in the aging population.

摘要

癌症是由体细胞突变和拷贝数改变(CNAs)的积累引起的。除了突变,这些拷贝数变化是癌症发展的关键特征。然而,一些肿瘤几乎没有任何 CNA,这在肿瘤发生中是一个显著的现象。头颈部鳞状细胞癌(HNSCC)是由致癌物暴露或人乳头瘤病毒(HPV)感染引起的。HPV 阴性的 HNSCC 通常具有许多 CNA 和 CDKN2A、TP53、FAT1 和 NOTCH1 的频繁突变。在这里,我们通过对 802 例口腔鳞状细胞癌(OCSCC)的遗传分析,展示了无或很少有 CNA(CNA-安静)的 HPV 阴性 HNSCC 的独特亚组的特征。总共 73 例 OCSCC(9.1%)被归类为 CNA-安静,729 例为 CNA-其他。CNA-安静组的特征是野生型 TP53、CASP8 和 HRAS 突变频繁,以及免疫抑制程度较低的肿瘤免疫微环境,调节性 T 细胞密度较低。与 CNA-其他 OCSCC 相比,CNA-安静 OCSCC 的患者年龄较大,女性较多,当前吸烟者较少,5 年总生存率较好。这项研究表明,CNA-安静的 OCSCC 应该被视为一个独特的、具有临床意义的亚类。鉴于这些肿瘤的临床特征,在老龄化人口中,具有这些肿瘤的患者群体将迅速增加。

相似文献

1
Hallmarks of a genomically distinct subclass of head and neck cancer.具有独特基因组亚类的头颈部癌症的特征。
Nat Commun. 2024 Oct 20;15(1):9060. doi: 10.1038/s41467-024-53390-3.
2
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.人类免疫缺陷病毒相关头颈部鳞状细胞癌中TP53突变的独特模式。
Cancer. 2018 Jan 1;124(1):84-94. doi: 10.1002/cncr.31063. Epub 2017 Oct 20.
3
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.一组头颈部癌症衍生细胞系的特征分析证实了存在独特的 TP53 功能完整拷贝数沉默亚类。
Oral Oncol. 2019 Nov;98:53-61. doi: 10.1016/j.oraloncology.2019.09.004. Epub 2019 Sep 18.
4
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.头颈癌细胞肿瘤基因组:精准分子疗法开发的平台。
Oncotarget. 2014 Oct 15;5(19):8906-23. doi: 10.18632/oncotarget.2417.
5
Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.人乳头瘤病毒和 p53 突变与日本人群头颈部鳞状细胞癌的关系。
Cancer Sci. 2014 Apr;105(4):409-17. doi: 10.1111/cas.12369. Epub 2014 Mar 30.
6
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.通过癌症基因靶向测序确定的头颈部鳞状细胞癌的基因组改变。
Ann Oncol. 2015 Jun;26(6):1216-1223. doi: 10.1093/annonc/mdv109. Epub 2015 Feb 23.
7
Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.卵巢癌衍生的拷贝数改变特征在头颈部鳞状细胞癌的放化疗治疗中具有预后价值。
Int J Cancer. 2020 Sep 15;147(6):1732-1739. doi: 10.1002/ijc.32962. Epub 2020 Mar 30.
8
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.靶向测序揭示TP53作为头颈部癌治疗后监测中的潜在诊断生物标志物。
Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196.
9
Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.饮酒和吸烟对头颈部癌遗传改变的不同影响。
PLoS One. 2013 Nov 20;8(11):e80828. doi: 10.1371/journal.pone.0080828. eCollection 2013.
10
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.对头颈鳞状细胞癌进行全面基因组分析,揭示 FGFR1 扩增和肿瘤基因组改变负担可作为生存预后的生物标志物。
Eur J Cancer. 2018 Mar;91:47-55. doi: 10.1016/j.ejca.2017.12.016. Epub 2018 Jan 11.

引用本文的文献

1
Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment.用免疫疗法靶向病毒驱动癌症的原型:关于肿瘤微环境中免疫原性的观点
Front Immunol. 2025 Aug 29;16:1631258. doi: 10.3389/fimmu.2025.1631258. eCollection 2025.
2
An effective multistage mouse model of esophageal carcinogenesis for preclinical and computational pathology applications.一种用于临床前和计算病理学应用的有效的多阶段食管癌发生小鼠模型。
Neoplasia. 2025 Aug 6;68:101217. doi: 10.1016/j.neo.2025.101217.
3
New insights into the genetic progression of cancer through longitudinal analysis of oral lesions.

本文引用的文献

1
Intratumor genetic heterogeneity and head and neck cancer relapse.肿瘤内遗传异质性与头颈部癌症复发。
Radiother Oncol. 2024 Feb;191:110087. doi: 10.1016/j.radonc.2024.110087. Epub 2024 Jan 6.
2
Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.通过多组学分析鉴定与黑色素瘤免疫治疗反应相关的生物标志物。
Comput Biol Med. 2023 Dec;167:107591. doi: 10.1016/j.compbiomed.2023.107591. Epub 2023 Oct 18.
3
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.
通过对口腔病变的纵向分析对癌症遗传进展的新见解。
J Pathol. 2025 Oct;267(2):155-167. doi: 10.1002/path.6449. Epub 2025 Jul 29.
4
LINC01518 functions as an oncogene in head and neck squamous cell carcinoma (HNSCC) by modulating miR-1-3p/Slug and miR-216b-5p/GRP78 axis.LINC01518通过调节miR-1-3p/Slug和miR-216b-5p/GRP78轴在头颈部鳞状细胞癌(HNSCC)中发挥癌基因作用。
Sci Rep. 2025 Jul 2;15(1):22589. doi: 10.1038/s41598-025-06934-6.
5
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease.口腔癌肿瘤微环境中肿瘤浸润性B细胞的丰富度是早期疾病的一个预后因素,并可改善晚期疾病的预后。
Cancers (Basel). 2025 Jan 1;17(1):113. doi: 10.3390/cancers17010113.
头颈部鳞状细胞癌的流行病学、危险因素和预防。
Med Sci (Basel). 2023 Jun 13;11(2):42. doi: 10.3390/medsci11020042.
4
Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.阐明口腔白斑病的遗传特征,以预测恶性转化。
Clin Cancer Res. 2023 Feb 1;29(3):602-613. doi: 10.1158/1078-0432.CCR-22-2210.
5
Oral cancer prediction by noninvasive genetic screening.无创性遗传筛查在口腔癌预测中的应用。
Int J Cancer. 2023 Jan 15;152(2):227-238. doi: 10.1002/ijc.34277. Epub 2022 Sep 18.
6
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.纳武利尤单抗联合伊匹单抗新辅助免疫治疗可诱导头颈部鳞状细胞癌患者发生主要病理缓解。
Nat Commun. 2021 Dec 22;12(1):7348. doi: 10.1038/s41467-021-26472-9.
7
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.基于预后基因表达聚类模型在人乳头瘤病毒阳性口咽癌中的临床有效性。
JCO Precis Oncol. 2021 Oct 27;5. doi: 10.1200/PO.21.00094. eCollection 2021.
8
missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.胰腺导管腺癌中的错义突变与增强的纤维化和免疫抑制微环境有关。
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). doi: 10.1073/pnas.2025631118.
9
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.新辅助免疫放疗可使局部晚期头颈部鳞状细胞癌获得高完全病理缓解率和临床病理降期。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2021-002485.
10
Immune evasion in HPV head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.HPV 头颈部癌前病变-癌症转化中的免疫逃逸是由涉及 9p 染色体缺失的非整倍体转换驱动的。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2022655118.